Improving the prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy by adding plasma SVEP1 to conventional clinical model including NT-proBNP
2 September 2024 (09:40 - 09:50)
Organised by: 
About the speaker
Columbia University Irving Medical Centre, New York (United States of America)
5 More presentations in this session
Doctor Z. Ashkir (Oxford, GB)
Doctor R. Ditaranto (Bologna, IT)
Doctor M. Jensovsky (Prague, CZ)
Access the full session
The Event
ESC Congress 2024
2 September 2024
09:40 CET
You may be interested in
Congress Session
Congress Session
